Llwytho...
Deferasirox for managing iron overload in people with myelodysplastic syndrome
BACKGROUND: The myelodysplastic syndrome (MDS) comprises a diverse group of haematopoietic stem cell disorders. Due to symptomatic anaemia, most people with MDS require supportive therapy including repeated red blood cell (RBC) transfusions. In combination with increased iron absorption, this contri...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cochrane Database Syst Rev |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley & Sons, Ltd
2014
|
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7202239/ https://ncbi.nlm.nih.gov/pubmed/25348770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007461.pub3 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|